Latest filing published 13 Oct 2021 for ChemoCentryx, Inc., €136.7M.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Vifor (International) Ltd: trading record in brief
This profile gathers the share dealings of Vifor (International) Ltd in ChemoCentryx, Inc. We count 67 filings; the first trade dates from 2 July 2020 and the latest from 12 October 2021.
On the market, this insider has only sold: 67 sales, €210.3M in total. Since January 2021: no purchases and 1 sale on the market.
The newest entry dates from 13 October 2021: an open-market sale of €136.7M, in ChemoCentryx, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Vifor (International) Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000,000 shares@ US$39.43100.0% of flowCommon Stock, par value $0.001 per shareSEC:0000899243-21-040141:0
1 of 1 declaration
